Related Experiment Videos
Drug delivery to the nervous system
1Department of Pharmacology and Therapeutics, McGill University, Montreal, Quebec, Canada. dmaysing@pharma.mcgill.ca
Trends in Biotechnology
|November 14, 1997
Summary
Microencapsulation offers a promising solution for delivering neuroactive compounds to the nervous system. This technique can overcome challenges like the blood-brain barrier and systemic side effects, improving drug efficacy for neurological disorders.
Area of Science:
- Neuroscience
- Pharmacology
- Biotechnology
Background:
- Drug delivery to the nervous system is hindered by the blood-brain barrier and systemic administration issues.
- Neurodegenerative disorders and neuroactive agents present unique delivery challenges.
- Peripheral nervous system offers greater accessibility but still faces stability and side effect concerns.
Purpose of the Study:
- To explore microencapsulation as a strategy for enhancing neuroactive compound delivery.
- To address limitations associated with current methods for treating nervous system disorders.
- To investigate overcoming blood-brain barrier and systemic administration challenges.
Main Methods:
- Microencapsulation of neuroactive compounds.
- Microencapsulation of living cells that produce neuroactive substances.
- Systemic administration of encapsulated agents.
Main Results:
- Microencapsulation can improve the stability of neuroactive compounds.
- This method may reduce systemic side effects associated with neuroactive agents.
- Potential to enhance drug accessibility to the central and peripheral nervous systems.
Conclusions:
- Microencapsulation is a viable strategy for overcoming key challenges in nervous system drug delivery.
- This approach holds promise for improved therapeutic outcomes in neurological conditions.
- Further research into microencapsulation techniques can advance treatments for neurodegenerative disorders.